Schuppan D - Search Results

1

Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.

Isokuortti E, Zhou Y, Peltonen M, Bugianesi E, Clement K, Bonnefont-Rousselot D, Lacorte JM, Gastaldelli A, Schuppan D, Schattenberg JM, Hakkarainen A, Lundbom N, Jousilahti P, Männistö S, Keinänen-Kiukaanniemi S, Saltevo J, Anstee QM, Yki-Järvinen H. Isokuortti E, et al. Among authors: schuppan d. Diabetologia. 2017 Oct;60(10):1873-1882. doi: 10.1007/s00125-017-4340-1. Epub 2017 Jun 29. Diabetologia. 2017. PMID: 28660493

2

Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors.

Gehrke N, Wörns MA, Huber Y, Hess M, Straub BK, Hövelmeyer N, Waisman A, Kim YO, Schuppan D, Galle PR, Schattenberg JM. Gehrke N, et al. Among authors: schuppan d. J Hepatol. 2016 Dec;65(6):1188-1197. doi: 10.1016/j.jhep.2016.06.026. Epub 2016 Jul 9. J Hepatol. 2016. PMID: 27405060

3

Hepatocellular carcinoma in nonalcoholic fatty liver disease: A link between oxidative stress and T-cell suppression.

Qureshi MA, Kim YO, Schuppan D. Qureshi MA, et al. Among authors: schuppan d. Hepatology. 2016 Nov;64(5):1794-1797. doi: 10.1002/hep.28815. Hepatology. 2016. PMID: 27629157 No abstract available.

4

Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes.

Karsdal MA, Henriksen K, Genovese F, Leeming DJ, Nielsen MJ, Riis BJ, Christiansen C, Byrjalsen I, Schuppan D. Karsdal MA, et al. Among authors: schuppan d. Diabetologia. 2017 Jan;60(1):50-59. doi: 10.1007/s00125-016-4094-1. Epub 2016 Sep 8. Diabetologia. 2017. PMID: 27631136 Clinical Trial.

5

Voluntary distance running prevents TNF-mediated liver injury in mice through alterations of the intrahepatic immune milieu.

Huber Y, Gehrke N, Biedenbach J, Helmig S, Simon P, Straub BK, Bergheim I, Huber T, Schuppan D, Galle PR, Wörns MA, Schuchmann M, Schattenberg JM. Huber Y, et al. Among authors: schuppan d. Cell Death Dis. 2017 Jun 22;8(6):e2893. doi: 10.1038/cddis.2017.266. Cell Death Dis. 2017. PMID: 28640248 Free PMC article.

6

Loss of organic cation transporter 3 (Oct3) leads to enhanced proliferation and hepatocarcinogenesis.

Vollmar J, Lautem A, Closs E, Schuppan D, Kim YO, Grimm D, Marquardt JU, Fuchs P, Straub BK, Schad A, Gründemann D, Schattenberg JM, Gehrke N, Wörns MA, Baumgart J, Galle PR, Zimmermann T. Vollmar J, et al. Among authors: schuppan d. Oncotarget. 2017 Dec 18;8(70):115667-115680. doi: 10.18632/oncotarget.23372. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383190 Free PMC article.

7

Predictors of advanced fibrosis in non-cirrhotic non-alcoholic fatty liver disease in Germany.

Labenz C, Huber Y, Kalliga E, Nagel M, Ruckes C, Straub BK, Galle PR, Wörns MA, Anstee QM, Schuppan D, Schattenberg JM. Labenz C, et al. Among authors: schuppan d. Aliment Pharmacol Ther. 2018 Nov;48(10):1109-1116. doi: 10.1111/apt.14976. Epub 2018 Oct 4. Aliment Pharmacol Ther. 2018. PMID: 30288767

8

Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis.

Farrell G, Schattenberg JM, Leclercq I, Yeh MM, Goldin R, Teoh N, Schuppan D. Farrell G, et al. Among authors: schuppan d. Hepatology. 2019 May;69(5):2241-2257. doi: 10.1002/hep.30333. Hepatology. 2019. PMID: 30372785 Free article. Review.

9

Dietary wheat amylase trypsin inhibitors promote features of murine non-alcoholic fatty liver disease.

Ashfaq-Khan M, Aslam M, Qureshi MA, Senkowski MS, Yen-Weng S, Strand S, Kim YO, Pickert G, Schattenberg JM, Schuppan D. Ashfaq-Khan M, et al. Among authors: schuppan d. Sci Rep. 2019 Nov 25;9(1):17463. doi: 10.1038/s41598-019-53323-x. Sci Rep. 2019. PMID: 31767938 Free PMC article.

10

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.

Harrison SA, Goodman Z, Jabbar A, Vemulapalli R, Younes ZH, Freilich B, Sheikh MY, Schattenberg JM, Kayali Z, Zivony A, Sheikh A, Garcia-Samaniego J, Satapathy SK, Therapondos G, Mena E, Schuppan D, Robinson J, Chan JL, Hagerty DT, Sanyal AJ. Harrison SA, et al. Among authors: schuppan d. J Hepatol. 2020 May;72(5):816-827. doi: 10.1016/j.jhep.2019.11.024. Epub 2019 Dec 27. J Hepatol. 2020. PMID: 31887369 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

654 results

Search Page